DREAM3 - Diabetes Risk Evaluation and Microalbuminuria in Saskatchewan First Nations Peoples

Not Applicable

Completed

• Conditions: Diabetes; Nutritional, Metabolic, Endocrine; Hypertension with diabetes

• Registration Number: ISRCTN34318453
• Lead Sponsor: Sunnybrook and Women's College Health Sciences Ctr (Canada)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-09-09
• Last Update Posted: 30 October 2017

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Eligible patients were Status Indians with the BTCIHS, age 18 or over (either sex), diagnosed with type 2 diabetes and persistent hypertension (greater than or equal too 130/80 mmHg).

Exclusion Criteria

Exclusion criteria included the use of beta-blockers, and women of childbearing age not able to use a reliable method of birth control and an inability to follow protocol.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Mean change in Systolic Blood Pressure from baseline to final visit at 12 months.

Secondary Outcome Measures

Name	Time	Method
All at 12 months:<br>1. Change in diastolic blood pressure between the two groups<br>2. Changes in urine albumin status<br>3. Proportion of patients achieving blood pressure targets<br>4. Adverse events